Health

Novoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-Jar

* Novoheart engineered the world's first "human heart-in-a-jar" as part of its proprietary MyHeart™ platform * Novoheart receives exclusive license from Harvard University to integrate pioneering bioreactor technology that accommodates model ventricles and optional valves into the "human hear...

2019-12-16 16:05 65

HOYA Group PENTAX Medical Cleared CE Mark for DISCOVERY(TM), an AI Assisted Polyp Detector

TOKYO, Dec. 16, 2019 /PRNewswire/ -- PENTAX Medical, a division of the HOYA Group, announced that it has cleared CE mark for DISCOVERY™, an innovative Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination....

2019-12-16 16:00 85

Ally Bridge Group Leads More Than US$140 million in Financings for Three New Medtech Investments

HONG KONG and NEW YORK, Dec. 16, 2019 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently led investments in three new medical technology companies. Each of the three companies is a commercial-stage, leading innovator re-settin...

2019-12-16 09:00 296

etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker

ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Florida, Dec. 16, 2019 /PRNewswire/ -- etectRx®, Inc. (etectRx), a privately-held digital health company, has announced U.S. Food and Drug Administration (FDA) clearance of its breakthrough patented i...

2019-12-16 07:06 253

Sands China Assembles 40,000 Hygiene Kits for Clean the World

MACAO, Dec. 13, 2019 /PRNewswire/ -- A total of around 350 volunteers from Sands China Ltd. and local community groups worked together Friday at The Venetian® Macao to build 40,000 of the 100,000 total hygiene kits of the Las Vegas Sands 2019 Global Disaster Relief & Community Preparedness Eve...

2019-12-13 21:01 960

AT & IT China 2020, to be held alongside CPhI & P-MEC China 2020, will showcase Intelligent Pharma High-tech solutions

SHANGHAI, Dec. 13, 2019 /PRNewswire/ -- AT & IT China 2020, organized by Informa Markets andChina Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., to take place at the Shanghai New Int...

2019-12-13 16:42 893

JLK Inspection, AI-based medical firm, listed on KOSDAQ

SEOUL, South Korea, Dec. 13, 2019 /PRNewswire/ -- JLK Inspection, a company specializing in world-class AI-based medical imaging solutions and a company of theBorn2Global Centre, was officially listed on the KOSDAQ index on December 11 th. ...

2019-12-13 09:49 492

Zurich Malaysia partners with DoctorOnCall to provide Malaysians a convenient way to manage their health

KUALA LUMPUR, Malaysia, Dec. 13, 2019 /PRNewswire/ -- Zurich Life Insurance Malaysia Berhad and Zurich Takaful Malaysia Berhad (Zurich Malaysia) have recently signed an agreement with leading online healthcare provider DoctorOnCall to extend complimentary* digital healthcare services to its new ...

2019-12-13 08:00 596

TSG Appoints New CEO to Lead Company's Asia Expansion

AUCKLAND, New Zealand, Dec. 13, 2019 /PRNewswire/ -- TSG, a leading provider of business management software, integrated payment solutions, and value-added services to the Health & Fitness and Childcare markets has appointed Olivier Vandercamme to the new position of CEO, Asia.  Mr. Vandercamme i...

2019-12-13 07:00 567

Akkad Holdings Asia and FKS Group Announce Global Partnership

DETROIT, Dec. 13, 2019 /PRNewswire/ -- Akkad Holdings Asia, LLC and the FKS Group today announced a global strategic partnership, FKS Akkad Capital, LP. The partnership will combine Akkad Holdings Asia's expertise, proven entrepreneurial success and its exceptional network with the know-how, res...

2019-12-13 05:49 513

Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS

TAIPEI and SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Senhwa Biosciences Inc. (TPEx: 6492), a clinical stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced positive results from its Phase 1 trial of CX-5461. C...

2019-12-13 04:00 309

Drug Manufacturers Eye Analytical Instrumentation to Reduce Operating Costs

SANTA CLARA, California, Dec. 12, 2019 /PRNewswire/ -- The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and nutraceuticals generated revenues of $3.05 billion in 2018 and is expected to grow at aCAGR of 7.0% to touch $4.91 billion in 2025. Pharmaceuticals were t...

2019-12-12 23:11 482

United Imaging's Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition

HOUSTON, Dec. 12, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, followed a strong appearance at the annual meeting of the Radiological Society ofNorth America (RSNA) with a win in a competition jointly organized by Facebook AI Researc...

2019-12-12 21:00 329

HemoCue AB, the Pioneer and Global leader in Hemoglobin (Hb) Point-of-care Testing (POCT) to Further Strengthen National Activities in the Combat against Anemia in India

HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation inNew Delhi and Mumbai, on December 2-4, 2019 STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- In 2019, Sweden and India celebrate ...

2019-12-12 16:11 323

World-class Performance with Assistance of Artificial Intelligence

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence. The system drastically reduces the time needed for pre-operatively planning of a hip implant in 3D, which has created a big interest for t...

2019-12-12 15:58 314

CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia

SUZHOU, China, Dec. 12, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received the approval from the Human Research Ethics Committee (HREC) in Australia, and the acknowledgement from Australia's Therapeutic Goods ...

2019-12-12 14:47 383

Mexican Society of Public Health (SMSP) signs MoU with StratifiCare to study effectiveness of Dengue prognostic test in Mexico

* Partnership with the Mexican Society of Public Health (SMSP) and Dengue Expert Group (DEG) leverages StratifiCare's deep experience in Dengue prognostication, and aims at reducing Dengue mortality rates inMexico. * SMSP in collaboration with DEG will provide clinical support for a study inv...

2019-12-12 13:26 337

Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019

BENGALURU, India, Dec. 12, 2019 /PRNewswire/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, brought together Key Opinion Leaders (KOLs), including physicians, scientists, healthcare professionals, government representatives, policy makers, and IDF members, at...

2019-12-12 09:00 324

Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics

SANTA CLARA, California, Dec. 11, 2019 /PRNewswire/ -- There has been a surge in industry-academia collaborations in thehuman microbiome therapeutics space. The partnerships betweenpharma/biotech companies and academic institutes are bringing together the research expertise of educational organiz...

2019-12-11 23:55 349

iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA

SINGAPORE, Dec. 11, 2019 /PRNewswire/ -- Specialty pharmaceutical company iX Biopharma Ltd(SGX:42C) ("iX Biopharma" or, "the Company") is pleased to announce that it has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding Wafermine, a sublin...

2019-12-11 22:00 301
12345 ... 781